[Federal Register Volume 61, Number 130 (Friday, July 5, 1996)] [Notices] [Page 35265] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-17063] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manfacturer of Controlled Substances; Notice of Application Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 13, 1996, Dupont Pharmaceuticals, The Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City, New York 11530, made application to the Drug Enforcement Administration (DEA) for registration as bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Oxycodone (9143).............................................. II Hydrocodone (9193)............................................ II Oxymorphone (9652)............................................ II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances to make finished products. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than September 3, 1996. Dated: June 27, 1996. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 96-17063 Filed 7-3-96; 8:45 am] BILLING CODE 4410-09-M